Ren et al. [10] disclosed that miR-146b-5p is a cholangiocarcinoma inhibitor through targeting TRAF6 to repress proliferation and stimulate apoptosis of cholangiocarcinoma cells. This evidence concerns the gene TRAF6 and cholangiocarcinoma.